710.82

0.66% -4.75

Mckesson Corporation (MCK)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Mckesson Corporation stock is traded at $710.82, with a volume of 409.46K. It is down -0.66% in the last 24 hours and down -2.39% over the past month. McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Previous Close:

$715.57

Open:

$715.46

24h Volume:

409.46K

Relative Volume:

0.47

Market Cap:

$88.78B

Revenue:

$359.05B

Net Income/Loss:

$3.30B

P/E Ratio:

27.52

EPS:

25.83

Net Cash Flow:

$5.23B

1W Performance:

-1.84%

1M Performance:

-2.39%

6M Performance:

+21.83%

1Y Performance:

+22.92%

1-Day Range:

$707.75

$718.00

1-Week Range:

$705.75

$728.37

52-Week Range:

$464.42

$737.89

Mckesson Corporation Stock (MCK) Company Profile

Name

Mckesson Corporation

Sector

Healthcare (1169)

Industry

Medical Distribution (12)

Phone

972-446-4800

Address

6555 STATE HIGHWAY 161, IRVING, TX

Employee

51,000

Twitter

@McKesson

Next Earnings Date

2024-11-06

Latest SEC Filings

MCK's Discussions on Twitter

Compare MCK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MCK Mckesson Corporation	710.82	90.44B	359.05B	3.30B	5.23B	25.83
COR Cencora Inc	294.65	57.77B	310.23B	1.69B	3.58B	8.62
CAH Cardinal Health Inc	161.02	39.25B	222.29B	1.56B	2.44B	6.41
HSIC Henry Schein Inc	70.64	9.24B	12.50B	314.00M	421.00M	2.44
AHG Akso Health Group Adr	1.6171	514.48M	2.22M	-5.63M	-1.68M	-0.24

Mckesson Corporation Stock (MCK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-04-24	Resumed	Mizuho	Neutral
Nov-07-24	Upgrade	Robert W. Baird	Neutral → Outperform
Sep-24-24	Downgrade	Robert W. Baird	Outperform → Neutral
Sep-05-24	Reiterated	Leerink Partners	Outperform
Aug-08-24	Reiterated	Mizuho	Neutral
Feb-26-24	Initiated	Leerink Partners	Outperform
Jan-03-24	Initiated	Barclays	Overweight
Dec-14-23	Initiated	Wells Fargo	Equal Weight
Mar-31-23	Initiated	Citigroup	Buy
Aug-22-22	Resumed	Morgan Stanley	Overweight
Jul-06-22	Downgrade	Argus	Buy → Hold
Jun-07-22	Upgrade	Deutsche Bank	Hold → Buy
Apr-01-22	Resumed	Credit Suisse	Outperform
Feb-04-22	Downgrade	Deutsche Bank	Buy → Hold
Jan-07-22	Upgrade	Credit Suisse	Neutral → Outperform
Nov-02-21	Reiterated	Barclays	Overweight
Nov-02-21	Reiterated	BofA Securities	Buy
Nov-02-21	Reiterated	Evercore ISI	Outperform
Nov-02-21	Reiterated	Jefferies	Buy
Mar-30-21	Upgrade	Argus	Hold → Buy
Nov-02-20	Upgrade	Barclays	Equal Weight → Overweight
Aug-04-20	Upgrade	Deutsche Bank	Hold → Buy
May-22-20	Upgrade	Wolfe Research	Peer Perform → Outperform
May-15-20	Upgrade	UBS	Neutral → Buy
Apr-23-20	Resumed	Credit Suisse	Neutral
Mar-18-20	Upgrade	Goldman	Neutral → Buy
Mar-13-20	Upgrade	Guggenheim	Neutral → Buy
Feb-07-20	Upgrade	Robert W. Baird	Neutral → Outperform
Jan-10-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-12-19	Initiated	Deutsche Bank	Hold
Aug-05-19	Downgrade	Wolfe Research	Outperform → Peer Perform
Jul-22-19	Initiated	Guggenheim	Neutral
Jan-17-19	Initiated	UBS	Neutral
Oct-26-18	Reiterated	Barclays	Equal Weight
Jul-20-18	Downgrade	Robert W. Baird	Outperform → Neutral
May-29-18	Reiterated	Leerink Partners	Mkt Perform
Mar-08-18	Initiated	Barclays	Equal Weight
Feb-27-18	Resumed	BofA/Merrill	Buy
Feb-02-18	Reiterated	Mizuho	Neutral
Jan-24-18	Upgrade	Jefferies	Hold → Buy

View All

Mckesson Corporation Stock (MCK) Latest News

Jul 15, 2025

McKesson ideaShare Empowers Independent Pharmacies to Innovate and Thrive - Yahoo Finance

Jul 15, 2025

Jul 14, 2025

Mckesson CEO Tyler S. Brian sells $13.7m in stock By Investing.com - Investing.com India

Jul 14, 2025

Mckesson CEO Tyler S. Brian sells $13.7m in stock - Investing.com

Jul 14, 2025

Synergy (NASDAQ: SNYR) Strategic Partnership w/ McKesson - openPR.com

Jul 14, 2025

Conference Recap: McKesson ideaShare Showcases Power of Independent Pharmacies - Drug Topics

Jul 14, 2025

McKesson (MCK) Partners with Synergy CHC for Canadian Distributi - GuruFocus

Jul 14, 2025

Synergy CHC Corp. (NASDAQ: SNYR) Secures Retail Deals with McKesson Canada and Others as FOCUSfactor Expansion Surges Across North America - The Manila Times

Jul 14, 2025

FOCUSfactor Secures Massive Retail Expansion: McKesson Canada Deal Opens Thousands of New Locations - Stock Titan

Jul 14, 2025

Government Contract Update: $1B payment to MCKESSON CORPORATION - Quiver Quantitative

Jul 14, 2025

Jul 13, 2025

McKesson ideaShare 2025: Pharmacy of the Year Finalist Keri Bates Reflects on Teamwork, Community, and the Road Ahead - Pharmacy Times

Jul 13, 2025

Independent Pharmacies Face Mounting Challenges in Modern Health Care Landscape | McKesson ideaShare - Drug Topics

Jul 13, 2025

Jul 12, 2025